查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447179

生命科学 IT 市场：按解决方案、类型和最终用户分类：2024-2033 年全球机会分析和产业预测

Life Sciences IT Market By Solution, By Type, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 268 Pages | 商品交期: 2-3个工作天内

价格

2023 年，全球生命科学 IT 市场价值为 213 亿美元，预计 2024 年至 2033 年复合年增长率为 11%，到 2033 年达到 625 亿美元。

生命科学IT市场-IMG1

生命科学IT是资讯科技在製药、生物科技和医疗保健等生命科学领域的应用。该 IT 专业在支持和推进生命科学产业的许多方面（从研发到製造和病患照护）方面发挥着至关重要的作用。生命科学 IT 软体和服务可协助科学家和研究人员管理大量生物和化学资料，并促进对生命科学研究各个方面的分析。该技术对于药物发现至关重要，有助于识别潜在的治疗标靶并简化开发新药。

由于生命科学产业越来越多地采用生命科学分析软体以及实验室自动化的发展趋势，生命科学 IT 市场预计将显着成长。

生命科学分析软体的日益普及已成为生命科学 IT 市场的关键驱动因素。这是因为人们越来越认识到高阶分析在增强研发流程、优化业务效率和促进资料主导决策方面发挥的关键作用。分析软体使生命科学公司能够利用巨量资料和复杂资料集的力量，使研究人员和科学家能够从大量资讯中提取有意义的见解。

先进分析工具的整合显着简化了药物发现和开发流程，实现了更准确的标靶识别、更深入地了解生物途径并加速了临床试验设计。例如，根据美国国家医学图书馆2020年的报告，巨量资料正在生物资料驱动的临床研究和其他研究领域中获得认可。此外，分析软体透过促进即时监控和报告，在确保法规遵循方面发挥关键作用，从而提高研究资料的整体品质和完整性。

此外，实验室自动化的上升趋势预计将成为生命科学 IT 市场成长的关键驱动力。生命科学 IT 解决方案旨在解决生命科学研究人员和专业人员面临的独特挑战，提供整合和优化实验室工作流程各个方面的综合平台。实验室自动化软体的主要好处之一是资料管理，这些系统有助于无缝组织、储存和搜寻大量复杂的科学资料。这不仅提高了资料准确性，还透过减少人工错误和减少管理任务上花费的时间来加快研究步伐。

此外，生命科学 IT 解决方案也为实验室流程（从样本追踪、实验效能到资料分析）的自动化做出了重大贡献。例如，全球生命科学解决方案公司 Thermo Fisher Scientific 提供 Momentum，这是实验室自动化的工作流程排程软体。该软体可让您在功能强大且易于使用的视觉化环境中定义、执行和监控科学流程和工作流程。其直觉的调度介面、智慧资料驱动的决策能力、卓越的连接性和灵活的模拟模式可协助您实现卓越的效能。

自动化不仅加快了工作速度，还确保了实验的一致性和可重复性。因此，实验室自动化的成长趋势预计将显着促进市场成长。

然而，资料安全和隐私问题已成为限制市场成长的主要问题。生命科学产业严重依赖收集、储存和分析大量敏感资料，包括病患记录、临床试验资讯和基因组资料。随着医疗保健流程变得数位化并采​​用云端处理和巨量资料分析等尖端技术，资料外洩和未授权存取的风险正在增加。因此，对资料安全和隐私的担忧预计将抑制市场成长。

生命科学 IT 市场按解决方案、类型、最终用户和地区进行细分。依解决方案分为药物发现资讯学、临床试验管理、生物资讯学、实验室资讯管理等。依类型分为软体和服务。依最终用户划分，可分为製药/生技公司、合约研发组织等。按地区划分，我们有北美（美国、加拿大、墨西哥）、欧洲（德国、英国、英国、义大利、西班牙其他欧洲国家地区）、亚太地区（中国、日本、澳洲、印度、韩国、其他亚太地区），在亚太地区（巴西、日本、阿拉伯、澳洲、印度、韩国和亚太其他地区）进行分析。

相关人员的主要利益

  • 本报告对 2023 年至 2033 年生命科学 IT 市场分析的细分市场、当前趋势、估计/趋势分析和动态进行了定量分析，以识别生命科学 IT 市场的整体机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析揭示了买家和供应商的潜力，帮助相关人员做出利润驱动的业务决策并加强供应商和买家网路。
  • 生命科学市场区隔的详细分析有助于识别市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场参与者定位有助于基准化分析，并提供对市场参与者当前地位的清晰了解。
  • 该报告包括对区域和全球生命科学市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要企业详细资料（Excel 格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 实验室自动化的趋势不断增长。
      • 对先进分析工具的需求不断增长
      • 生命科学 IT 解决方案在药物发现过程中的采用率很高。
    • 抑制因素
      • 资料隐私和安全问题
    • 机会
      • 生命科学IT技术的技术进步

第 4 章生命科学 IT 市场：按解决方案

  • 概述
  • 药物发现资讯学
  • 临床试验管理
  • 生物资讯学
  • 临床试验资讯管理
  • 其他的

第五章生命科学 IT 市场：依类型

  • 概述
  • 软体
  • 服务

第 6 章 生命科学 IT 市场：以最终使用者划分

  • 概述
  • 製药和生物技术公司
  • 研究开发合约组织
  • 其他的

第 7 章 生命科学 IT 市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第八章 竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2023年主要企业定位

第九章 公司简介

  • Thermo Fisher Scientific Inc.
  • Qiagen NV.
  • Agilent Technologies, Inc.
  • Oracle Corporation
  • Revvity, Inc.
  • Clario
  • IBM Corporation
  • DNAnexus, Inc.
  • Genedata AG
  • Illumina, Inc.
Product Code: A310277

The global life sciences IT market was valued at $21.3 billion in 2023, and is projected to reach $62.5 billion by 2033, growing at a CAGR of 11% from 2024 to 2033.

Life Sciences IT Market - IMG1

Life science IT is the application of information technology in the field of life sciences, including pharmaceuticals, biotechnology, and healthcare. This specialized branch of IT plays a pivotal role in supporting and advancing various aspects of the life sciences industry, from R&D to manufacturing and patient care. Life science IT software and services aid scientists and researchers in managing vast amounts of biological and chemical data, facilitating the analysis of various aspects of life sciences research. This technology is crucial for drug discovery, helping to streamline the identification of potential therapeutic targets and the development of new drugs.

The life science IT market is expected to register significant growth, owing to rise in adoption of life sciences analytical software in life sciences industry, and growing trend towards laboratory automation.

Rise in adoption of the life sciences analytical software has emerged as major driver for the life science IT market. This can be attributed to increasing awareness about the crucial role that advanced analytics plays in enhancing R&D processes, optimizing operational efficiency, and facilitating data-driven decision-making. Analytical software enables life sciences companies to harness the power of big data and complex datasets; thereby empowering researchers and scientists to extract meaningful insights from vast pools of information.

The integration of sophisticated analytics tools has significantly streamlined drug discovery and development processes, allowing for more precise target identification, better understanding of biological pathways, and accelerated clinical trial designs. For instance, according to a 2020 report by National Library of Medicine, big data is gaining recognition in clinical studies and other research areas driven by biological data. Moreover, analytical software plays a crucial role in ensuring regulatory compliance, as it facilitates real-time monitoring and reporting; thereby enhancing the overall quality and integrity of research data.

Furthermore, the growing trend towards the laboratory automation is expected to act as a major driver for the growth of the life science IT market. Life science IT solutions are designed to address the unique challenges faced by life sciences researchers and professionals, offering a comprehensive platform that integrates and optimizes various facets of laboratory workflows. One of the key advantages of laboratory automation software lies in data management, where these software systems facilitate seamless organization, storage, and retrieval of vast volumes of complex scientific data. This not only enhances data accuracy but also accelerates the pace of research by reducing manual errors and the time spent on administrative tasks.

Furthermore, life science IT solutions contribute significantly to the automation of laboratory processes, ranging from sample tracking and experiment execution to data analysis. For instance, Thermo Fisher Scientific Inc., a global life science solution company provides Momentum workflow scheduling software for laboratory automation. It enables users to define, execute, and monitor scientific processes and workflows in a powerful yet easy-to-use visual environment. Its intuitive scheduling interface, intelligent data-driven decision-making capabilities, superior connectivity, and flexible simulation modes help attain superior performance.

Automation not only expedites tasks but also ensures consistency and reproducibility in experiments, which is a crucial factor in maintaining high-quality research standards. Thus, the growing trend towards laboratory automation is expected to contribute significantly in the growth of the market.

However, data security and privacy concerns have emerged as major concerns restraining the growth of the market. The life sciences industry relies heavily on the collection, storage, and analysis of vast amounts of sensitive and confidential data, including patient records, clinical trial information, and genomic data. With increase in digitization of healthcare processes and the adoption of advanced technologies such as cloud computing and big data analytics, the risk of data breaches and unauthorized access has escalated. Thus, data security and privacy concerns are expected to restrain the growth of the market.

The life science IT market is segmented on the basis of solution, type, end user, and region. By solution, it is divided into drug discovery informatics, clinical trial management, bioinformatics, laboratory information management, and others. By type, it is bifurcated into software and services. By end user, it is segmented into pharmaceutical and biotechnology companies, contract R&D organizations, and other. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Thermo Fisher Scientific Inc, Illumina, Qiagen N.V., Revvity, Inc, Agilent Technologies Inc, Oracle, Clario Inc, IBM Corp, DNAnexus Inc, and Genedata AG.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the life sciences it market analysis from 2023 to 2033 to identify the prevailing life sciences it market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the life sciences it market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global life sciences it market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Solution

  • Drug Discovery Informatics
  • Clinical Trial Management
  • Bioinformatics
  • Laboratory Information Management
  • Others

By Type

  • Software
  • Service

By End User

  • Others
  • Pharmaceutical and Biotechnology Companies
  • Contract Research and Development Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Thermo Fisher Scientific Inc.
    • Qiagen NV.
    • Agilent Technologies, Inc.
    • Oracle Corporation
    • Clario
    • IBM Corporation
    • Genedata AG
    • Illumina, Inc.
    • Revvity, Inc.
    • DNAnexus, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growing trend towards laboratory automation.
      • 3.4.1.2. Rise in demand for advance analytical tool
      • 3.4.1.3. High adoption of life sciences IT solutions in drug discovery process.
    • 3.4.2. Restraints
      • 3.4.2.1. Data privacy and security concerns
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancement in life sciences IT technology

CHAPTER 4: LIFE SCIENCES IT MARKET, BY SOLUTION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Drug Discovery Informatics
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Clinical Trial Management
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Bioinformatics
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Laboratory Information Management
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Others
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: LIFE SCIENCES IT MARKET, BY TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Software
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Service
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: LIFE SCIENCES IT MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical and Biotechnology Companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Contract Research and Development Organizations
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: LIFE SCIENCES IT MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Solution
    • 7.2.3. Market size and forecast, by Type
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Solution
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Solution
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Solution
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Solution
    • 7.3.3. Market size and forecast, by Type
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Solution
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Solution
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Solution
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Solution
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Solution
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Solution
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Solution
    • 7.4.3. Market size and forecast, by Type
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Solution
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Solution
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Solution
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Solution
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Solution
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Solution
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Solution
    • 7.5.3. Market size and forecast, by Type
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Solution
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Solution
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Solution
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Solution
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Thermo Fisher Scientific Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Qiagen NV.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Agilent Technologies, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Oracle Corporation
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Revvity, Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Key strategic moves and developments
  • 9.6. Clario
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Key strategic moves and developments
  • 9.7. IBM Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. DNAnexus, Inc.
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Key strategic moves and developments
  • 9.9. Genedata AG
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Key strategic moves and developments
  • 9.10. Illumina, Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 02. LIFE SCIENCES IT MARKET FOR DRUG DISCOVERY INFORMATICS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 03. LIFE SCIENCES IT MARKET FOR CLINICAL TRIAL MANAGEMENT, BY REGION, 2023-2033 ($MILLION)
  • TABLE 04. LIFE SCIENCES IT MARKET FOR BIOINFORMATICS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 05. LIFE SCIENCES IT MARKET FOR LABORATORY INFORMATION MANAGEMENT, BY REGION, 2023-2033 ($MILLION)
  • TABLE 06. LIFE SCIENCES IT MARKET FOR OTHERS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 07. GLOBAL LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 08. LIFE SCIENCES IT MARKET FOR SOFTWARE, BY REGION, 2023-2033 ($MILLION)
  • TABLE 09. LIFE SCIENCES IT MARKET FOR SERVICE, BY REGION, 2023-2033 ($MILLION)
  • TABLE 10. GLOBAL LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 11. LIFE SCIENCES IT MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2033 ($MILLION)
  • TABLE 12. LIFE SCIENCES IT MARKET FOR CONTRACT RESEARCH AND DEVELOPMENT ORGANIZATIONS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 13. LIFE SCIENCES IT MARKET FOR OTHERS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 14. LIFE SCIENCES IT MARKET, BY REGION, 2023-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA LIFE SCIENCES IT MARKET, BY COUNTRY, 2023-2033 ($MILLION)
  • TABLE 19. U.S. LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 20. U.S. LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 21. U.S. LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 22. CANADA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 23. CANADA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 24. CANADA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 25. MEXICO LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 26. MEXICO LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 27. MEXICO LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 28. EUROPE LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 29. EUROPE LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 30. EUROPE LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 31. EUROPE LIFE SCIENCES IT MARKET, BY COUNTRY, 2023-2033 ($MILLION)
  • TABLE 32. GERMANY LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 33. GERMANY LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 34. GERMANY LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 35. FRANCE LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 36. FRANCE LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 37. FRANCE LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 38. UK LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 39. UK LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 40. UK LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 41. ITALY LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 42. ITALY LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 43. ITALY LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 44. SPAIN LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 45. SPAIN LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 46. SPAIN LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 47. REST OF EUROPE LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 50. ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY COUNTRY, 2023-2033 ($MILLION)
  • TABLE 54. JAPAN LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 55. JAPAN LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 56. JAPAN LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 57. CHINA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 58. CHINA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 59. CHINA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 60. INDIA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 61. INDIA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 62. INDIA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 63. AUSTRALIA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 64. AUSTRALIA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 65. AUSTRALIA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 72. LAMEA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 73. LAMEA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 74. LAMEA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 75. LAMEA LIFE SCIENCES IT MARKET, BY COUNTRY, 2023-2033 ($MILLION)
  • TABLE 76. BRAZIL LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 77. BRAZIL LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 78. BRAZIL LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 79. SAUDI ARABIA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 80. SAUDI ARABIA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 81. SAUDI ARABIA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 82. SOUTH AFRICA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 83. SOUTH AFRICA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 84. SOUTH AFRICA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 85. REST OF LAMEA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 86. REST OF LAMEA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 87. REST OF LAMEA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 88. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 89. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 90. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 91. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 92. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 93. QIAGEN NV.: KEY EXECUTIVES
  • TABLE 94. QIAGEN NV.: COMPANY SNAPSHOT
  • TABLE 95. QIAGEN NV.: PRODUCT SEGMENTS
  • TABLE 96. QIAGEN NV.: PRODUCT PORTFOLIO
  • TABLE 97. QIAGEN NV.: KEY STRATERGIES
  • TABLE 98. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 99. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 100. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
  • TABLE 101. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 102. ORACLE CORPORATION: KEY EXECUTIVES
  • TABLE 103. ORACLE CORPORATION: COMPANY SNAPSHOT
  • TABLE 104. ORACLE CORPORATION: SERVICE SEGMENTS
  • TABLE 105. ORACLE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 106. REVVITY, INC.: KEY EXECUTIVES
  • TABLE 107. REVVITY, INC.: COMPANY SNAPSHOT
  • TABLE 108. REVVITY, INC.: PRODUCT SEGMENTS
  • TABLE 109. REVVITY, INC.: PRODUCT PORTFOLIO
  • TABLE 110. REVVITY, INC.: KEY STRATERGIES
  • TABLE 111. CLARIO: KEY EXECUTIVES
  • TABLE 112. CLARIO: COMPANY SNAPSHOT
  • TABLE 113. CLARIO: PRODUCT SEGMENTS
  • TABLE 114. CLARIO: PRODUCT PORTFOLIO
  • TABLE 115. CLARIO: KEY STRATERGIES
  • TABLE 116. IBM CORPORATION: KEY EXECUTIVES
  • TABLE 117. IBM CORPORATION: COMPANY SNAPSHOT
  • TABLE 118. IBM CORPORATION: PRODUCT SEGMENTS
  • TABLE 119. IBM CORPORATION: PRODUCT PORTFOLIO
  • TABLE 120. DNANEXUS, INC.: KEY EXECUTIVES
  • TABLE 121. DNANEXUS, INC.: COMPANY SNAPSHOT
  • TABLE 122. DNANEXUS, INC.: PRODUCT SEGMENTS
  • TABLE 123. DNANEXUS, INC.: PRODUCT PORTFOLIO
  • TABLE 124. DNANEXUS, INC.: KEY STRATERGIES
  • TABLE 125. GENEDATA AG: KEY EXECUTIVES
  • TABLE 126. GENEDATA AG: COMPANY SNAPSHOT
  • TABLE 127. GENEDATA AG: PRODUCT SEGMENTS
  • TABLE 128. GENEDATA AG: PRODUCT PORTFOLIO
  • TABLE 129. GENEDATA AG: KEY STRATERGIES
  • TABLE 130. ILLUMINA, INC.: KEY EXECUTIVES
  • TABLE 131. ILLUMINA, INC.: COMPANY SNAPSHOT
  • TABLE 132. ILLUMINA, INC.: PRODUCT SEGMENTS
  • TABLE 133. ILLUMINA, INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. LIFE SCIENCES IT MARKET, 2023-2033
  • FIGURE 02. SEGMENTATION OF LIFE SCIENCES IT MARKET,2023-2033
  • FIGURE 03. TOP IMPACTING FACTORS IN LIFE SCIENCES IT MARKET (2023 TO 2024)
  • FIGURE 04. TOP INVESTMENT POCKETS IN LIFE SCIENCES IT MARKET (2024-2033)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL LIFE SCIENCES IT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. LIFE SCIENCES IT MARKET, BY SOLUTION, 2023 AND 2033(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR DRUG DISCOVERY INFORMATICS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR CLINICAL TRIAL MANAGEMENT, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR BIOINFORMATICS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR LABORATORY INFORMATION MANAGEMENT, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR OTHERS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 17. LIFE SCIENCES IT MARKET, BY TYPE, 2023 AND 2033(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR SOFTWARE, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR SERVICE, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 20. LIFE SCIENCES IT MARKET, BY END USER, 2023 AND 2033(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR CONTRACT RESEARCH AND DEVELOPMENT ORGANIZATIONS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR OTHERS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 24. LIFE SCIENCES IT MARKET BY REGION, 2023 AND 2033(%)
  • FIGURE 25. U.S. LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 26. CANADA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 27. MEXICO LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 28. GERMANY LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 29. FRANCE LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 30. UK LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 31. ITALY LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 32. SPAIN LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 33. REST OF EUROPE LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 34. JAPAN LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 35. CHINA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 36. INDIA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 37. AUSTRALIA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 38. SOUTH KOREA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 39. REST OF ASIA-PACIFIC LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 40. BRAZIL LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 41. SAUDI ARABIA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 42. SOUTH AFRICA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 43. REST OF LAMEA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 44. TOP WINNING STRATEGIES, BY YEAR (2021-2024)
  • FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2024)
  • FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY (2021-2024)
  • FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 48. COMPETITIVE DASHBOARD
  • FIGURE 49. COMPETITIVE HEATMAP: LIFE SCIENCES IT MARKET
  • FIGURE 50. TOP PLAYER POSITIONING, 2023
  • FIGURE 51. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 52. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 53. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 54. QIAGEN NV.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 55. QIAGEN NV.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. QIAGEN NV.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. AGILENT TECHNOLOGIES, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 59. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 61. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 64. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 66. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 67. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 68. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 69. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)